鼻咽癌放疗后分泌性中耳炎:发病机制、管理与预防综述
本综述聚焦鼻咽癌放疗后分泌性中耳炎(OME),系统梳理其发病机制(咽鼓管功能障碍、肿瘤侵犯、感染与免疫因素)、生物标志物早期检测潜力及现有治疗策略的局限,并探讨放疗降阶梯与个体化靶区勾画等预防导向策略。
要点
- 放疗后OME在鼻咽癌幸存者中高发,严重损害生活质量。
- 现有保守、物理及手术治疗仅获短暂症状缓解,长期疗效有限。
- 生物标志物有望早期检测和预测放疗诱导毒性。
核心结论
- 鼻咽癌放疗后OME发病机制涉及咽鼓管功能障碍、肿瘤侵犯及感染免疫因素,现有治疗长期疗效有限,亟需预防导向策略。
研究设计与样本
- 本文为综述,综合近期文献分析鼻咽癌放疗后OME的发病机制、管理与预防。
主要发现
- 放疗后OME在鼻咽癌幸存者中高发且严重影响生活质量。
- 生物标志物在早期检测和预测放疗诱导毒性方面显示潜力。
- 保守药物、物理及手术治疗仅获短暂症状缓解,长期疗效有限。
- 新型治疗模式显示潜力,但有效性需进一步验证。
临床怎么用
- 临床应关注鼻咽癌放疗后OME的早期识别与生物标志物应用。
- 现有治疗可短期缓解症状,但需认识其长期疗效局限。
- 可探讨放疗降阶梯与个体化靶区勾画以减少耳毒性并维持肿瘤控制。
局限性
- 综述未报告具体样本量、效应量或统计学指标。
- 新型治疗模式的疗效尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In recent years, multimodal treatment approaches have significantly improved survival outcomes for patients with nasopharyngeal carcinoma, drawing increased clinical attention to treatment-related complications. One particularly prevalent and debilitating complication is postirradiation otitis media with effusion (OME), which severely impacts the quality of life in nasopharyngeal carcinoma survivors. This review comprehensively examines the pathogenesis of postirradiation OME, emphasizing the roles of radiation-induced Eustachian tube dysfunction, direct tumor invasion, as well as infectious and immunological factors. Emerging evidence on biomarkers demonstrates potential in the early detection and prediction of radiation-induced toxicity. Current therapeutic strategies, including conservative medical management, physical therapies, and surgical interventions, have demonstrated transient symptomatic relief and are limited in achieving long-term efficacy. Although novel treatment modalities show potential in addressing these challenges, their effectiveness requires further validation. Consequently, there is an urgent need to develop prevention-oriented strategies. Radiation therapy de-escalation and personalized target delineation are discussed as potential approaches to minimize ototoxicity while maintaining effective tumor control. By synthesizing recent literature, this review aims to provide valuable clinical insights and highlight future research directions for the management of postirradiation OME.
引用
- Jiang M, Li H, Chen C, et al. Postirradiation Otitis Media With Effusion in Nasopharyngeal Carcinoma: A Comprehensive Review of Pathogenesis, Management, and Prevention. Int J Radiat Oncol Biol Phys. 2025. PMID: 40582599. doi:10.1016/j.ijrobp.2025.06.3875
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。